The estimated Net Worth of Charles Brynelsen is at least $5.42 millió dollars as of 26 February 2021. Mr. Brynelsen owns over 1,002 units of Abbott Laboratories stock worth over $5,077,930 and over the last 7 years he sold ABT stock worth over $337,729. In addition, he makes $0 as Senior Vice President - Abbott Vascular at Abbott Laboratories.
Charles has made over 3 trades of the Abbott Laboratories stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 1,002 units of ABT stock worth $120,851 on 26 February 2021.
The largest trade he's ever made was selling 1,781 units of Abbott Laboratories stock on 28 February 2020 worth over $138,722. On average, Charles trades about 344 units every 66 days since 2017. As of 26 February 2021 he still owns at least 43,550 units of Abbott Laboratories stock.
You can see the complete history of Mr. Brynelsen stock trades at the bottom of the page.
Charles R. Brynelsen serves as Senior Vice President - Abbott Vascular of the Company. He serves as Managing Director, CB Business Advisors, Inc. (a medical device consulting firm) from 2016 to 2017. Senior Vice President and President, Medtronic Early Technologies, Medtronic plc (a global medical device company) from 2015 to 2016. President, Early Technologies, Covidien plc (a global healthcare products company) from 2013 to 2015 .
Charles Brynelsen is 63, he's been the Senior Vice President - Abbott Vascular of Abbott Laboratories since 2017. There are 8 older and 33 younger executives at Abbott Laboratories. The oldest executive at Abbott Laboratories is Samuel Scott, 75, who is the Independent Director.
Charles's mailing address filed with the SEC is 100 ABBOTT PARK ROAD, , ABBOTT PARK, IL, 60064.
Over the last 24 years, insiders at Abbott Laboratories have traded over $388,257,551 worth of Abbott Laboratories stock and bought 1,028,477 units worth $44,923,618 . The most active insiders traders include Miles D White, Richard A Gonzalez és Jeffrey M Leiden. On average, Abbott Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of $4,003,344. The most recent stock trade was executed by John A. Jr. Mccoy on 1 September 2024, trading 27 units of ABT stock currently worth $3,100.
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.
Abbott Laboratories executives and other stock owners filed with the SEC include: